This inventor holds 8 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 1991-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- King of Prussia, PA (US) (1991)
- Collegeville, PA (US) (1998 - 2005)
Company Filing History:
Years Active: 1991-2005
Title: The Innovative Contributions of Kathryn J Hofmann
Introduction
Kathryn J Hofmann is an esteemed inventor based in Collegeville, PA, whose work has significantly impacted the field of virology and human health. With a remarkable portfolio of 8 patents, she is recognized for her contributions in developing DNA molecules for critical health applications related to human papillomavirus (HPV).
Latest Patents
Among her most notable recent patents are the DNA encoding for human papillomavirus type 18 and type 6A. The invention focused on DNA molecules that encode purified human papillomavirus type 18 as well as derivatives thereof, marking a step forward in understanding and diagnosing HPV. Another key patent involves DNA molecules encoding purified human papillomavirus type 6A and its derived compounds, showcasing her commitment to advancing healthcare through innovative biotechnological solutions.
Career Highlights
Kathryn is currently affiliated with Merck & Company, Inc., where she continues to engage in groundbreaking research. Her work has positioned her as a leading figure in the life sciences sector, particularly in the area of infectious diseases and vaccine development. Her innovative approaches have garnered wide recognition within the scientific community.
Collaborations
Throughout her career, Kathryn has collaborated with notable colleagues, including Kathrin Ute Jansen and Michael P Neeper. These partnerships have enhanced her research capabilities and contributed to the development of significant healthcare solutions, further emphasizing the importance of teamwork in scientific innovation.
Conclusion
Kathryn J Hofmann's pioneering work in developing DNA molecules related to human papillomavirus is a testament to her dedication and expertise in the field. With several patents to her name and a role at Merck & Company, Inc., her contributions continue to shape the future of medical research and public health. Her trajectory serves as an inspiration for aspiring inventors looking to make meaningful advancements in science and healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile